首页> 外国专利> Composition, processes to treat cancer, to elicit T lymphocytes that infiltrate a mammalian tumor, to elicit a delayed hypersensitivity response to a mammalian tumor, and to prepare hapten-modified tumor cell membranes, and, isolated membrane of mammalian tumor cell

Composition, processes to treat cancer, to elicit T lymphocytes that infiltrate a mammalian tumor, to elicit a delayed hypersensitivity response to a mammalian tumor, and to prepare hapten-modified tumor cell membranes, and, isolated membrane of mammalian tumor cell

机译:组成,治疗癌症的方法,引发渗入哺乳动物肿瘤的T淋巴细胞,引起对哺乳动物肿瘤的迟发型超敏反应,制备半抗原修饰的肿瘤细胞膜以及哺乳动物肿瘤细胞的分离膜

摘要

"COMPOSITION, PROCESSES TO TREAT CANCER, AND TO PREPARE A HAPPENE-MODIFIED TUMOR CELL MEMBRANE, DOMESTIC ANIMAL TUMOR CELL ISOLATED MEMBRANE, AND PROCESSES TO ELICITATE T LYMPHOCYTES THAT INFILITATE AN EMPHASIS OF A TYPE LYMPHIC NUMBER IN ONE HUMAN RESUME. INFLAMMATORY IMMUNE TO A MAMMALIAN TUMOR, AND TO ELICIT A TYPE HYPERSENSITIVITY RESPONSE DELAYED TO A MAMMALIAN TUMOR ". The present invention is directed to isolated tumor cell membranes, their compositions, processes for producing the membranes and compositions, and cancer treatment processes. The compositions of the present invention include a composition prepared from a tumor cell that is modified by hapten. Tumor cell membranes and compositions of the invention have the properties, when administered to a mammal suffering from a malignant tumor of the same type as said tumor cell, to elicit T lymphocytes that infiltrate the mammalian tumor and to elicit a inflammatory immune response against the mammalian tumor, and to elicit a delayed type hypersensitivity response to the mammalian tumor. The membranes and compositions of the invention also stimulate T cells in vitro. The processes of the present invention are directed towards the treatment of cancer, comprising administering a therapeutically effective amount of a tumor cell membrane. The present invention is also directed to a process of producing a hapten modified tumor cell membranes and to dosage forms containing the membranes.
机译:“组成,治疗癌症的过程,以及制备经肝癌修饰的肿瘤细胞膜,家畜与动物肿瘤细胞分离的膜的过程,以及促使T型淋巴瘤被感染的方法,该过程使人感染了一种类型的淋巴结。哺乳动物肿瘤,并引起对哺乳动物肿瘤的迟发型超敏反应”。本发明涉及分离的肿瘤细胞膜,其组合物,制备该膜和组合物的方法以及癌症治疗方法。本发明的组合物包括由被半抗原修饰的肿瘤细胞制备的组合物。当给予患有与所述肿瘤细胞相同类型的恶性肿瘤的哺乳动物时,本发明的肿瘤细胞膜和组合物具有引发浸润哺乳动物肿瘤的T淋巴细胞和引发针对哺乳动物的炎性免疫应答的特性。并引起对哺乳动物肿瘤的迟发型超敏反应。本发明的膜和组合物还在体外刺激T细胞。本发明的方法涉及癌症的治疗,包括给予治疗有效量的肿瘤细胞膜。本发明还涉及半抗原修饰的肿瘤细胞膜的生产方法以及包含该膜的剂型。

著录项

  • 公开/公告号BR9907912A

    专利类型

  • 公开/公告日2000-10-24

    原文格式PDF

  • 申请/专利权人 THOMAS JEFFERSON UNIVERSITY;

    申请/专利号BR19999907912

  • 发明设计人 DAVID BERD;TAKAMI SATO;

    申请日1999-02-17

  • 分类号A61K35/00;

  • 国家 BR

  • 入库时间 2022-08-22 01:56:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号